Description
Initial therapeutic antibodies were usually murine molecules. These murine-derived antibodies have a short half-life in vivo, a limited penetration into tumour sites and inadequately recruit host effector functions. Therefore, chimeric antibodies have gradually replaced them in therapeutic applications, being a new generation of therapeutic candidates.
Chimeric Antibody
Creative Biolabs
Download Data Sheet
Similar Products
Thank You!
Your inquiry has been received.
Create an account by adding a password
Why create an account?
- Auto-complete inquiry forms
- View and manage all your past messages
- Save products to your favorites
- Close your account anytime — no hassle